147 related articles for article (PubMed ID: 11255865)
21. [Neuraminidase inhibitors against influenza].
Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
[No Abstract] [Full Text] [Related]
22. [Antiinfluenza-drugs and the standard of the use].
Matsumoto K
Nihon Rinsho; 2000 Nov; 58(11):2283-7. PubMed ID: 11225318
[TBL] [Abstract][Full Text] [Related]
23. [Flu and antiviral agents....].
Vallée JP
Presse Med; 2000 Jan; 29(2):84-5. PubMed ID: 10682036
[No Abstract] [Full Text] [Related]
24. [Criteria for the use of anti-influenza agents].
Kashiwagi S
Nihon Rinsho; 2003 Nov; 61(11):1963-6. PubMed ID: 14619439
[TBL] [Abstract][Full Text] [Related]
25. [Drug regulatory agency comments on the editorial about the new influenza drugs].
Tokola O; Pasanen M
Duodecim; 2000; 116(6):626-7. PubMed ID: 11787114
[No Abstract] [Full Text] [Related]
26. [New flu therapy. Progress or burden for the budget?].
Vogel GE
MMW Fortschr Med; 2000 Feb; 142(8):14. PubMed ID: 10810861
[No Abstract] [Full Text] [Related]
27. [Influenza].
Sugaya N
Nihon Rinsho; 2003 Feb; 61 Suppl 2():135-40. PubMed ID: 12722202
[No Abstract] [Full Text] [Related]
28. A new antiviral agent for influenza--is there a clinical niche?
Couch RB
N Engl J Med; 1997 Sep; 337(13):927-8. PubMed ID: 9302309
[No Abstract] [Full Text] [Related]
29. [A revolutionary change in the diagnosis and treatment of influenza].
Sugaya N
Uirusu; 2002 Jun; 52(1):47-53. PubMed ID: 12227179
[No Abstract] [Full Text] [Related]
30. Zanamivir in the prevention of influenza among healthy adults.
Bower DJ; Slawson JG
J Fam Pract; 1999 Oct; 48(10):748. PubMed ID: 12224667
[No Abstract] [Full Text] [Related]
31. [Emerging infectious diseases--influenza].
Matsumoto K
Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2033-8. PubMed ID: 9480306
[No Abstract] [Full Text] [Related]
32. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
33. Neuraminidase inhibitors for influenza.
Moscona A
N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481
[No Abstract] [Full Text] [Related]
34. Updated treatment for influenza A and B.
Montalto NJ; Gum KD; Ashley JV
Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
[TBL] [Abstract][Full Text] [Related]
35. Respiratory distress associated with zanamivir.
Williamson JC; Pegram PS
N Engl J Med; 2000 Mar; 342(9):661-2. PubMed ID: 10702061
[No Abstract] [Full Text] [Related]
36. NICE advises against prescribing zanamivir until further evidence emerges.
Commun Dis Rep CDR Wkly; 1999 Oct; 9(42):371. PubMed ID: 10582390
[No Abstract] [Full Text] [Related]
37. Neuraminidase inhibitors for treatment of influenza.
Ebell MH
Am Fam Physician; 2004 Jun; 69(12):2824. PubMed ID: 15222647
[No Abstract] [Full Text] [Related]
38. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.
Boivin G; Goyette N; Hardy I; Aoki F; Wagner A; Trottier S
J Infect Dis; 2000 Apr; 181(4):1471-4. PubMed ID: 10762579
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
Calfee DP; Peng AW; Hussey EK; Lobo M; Hayden FG
Antivir Ther; 1999; 4(3):143-9. PubMed ID: 12731753
[TBL] [Abstract][Full Text] [Related]
40. [Neuraminidase inhibitor].
Kaji M
Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
